Joann Lindenfeld Selected Research

Anticoagulant Reversal Agents

9/2019

Anticoagulation Reversal and Risk of Thromboembolic Events Among Heart Transplant Recipients Bridged with Durable Mechanical Circulatory Support Devices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joann Lindenfeld Research Topics

Disease

22	Heart Failure 01/2022 - 04/2004
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 12/2019
2	Congenital Heart Defects (Congenital Heart Defect) 01/2022 - 11/2018
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2013 - 08/2009
2	Neoplasms (Cancer) 09/2010 - 05/2010
1	Pulmonary Edema 01/2022
1	Cardiogenic Shock 01/2022
1	COVID-19 09/2021
1	Primary Graft Dysfunction 09/2021
1	Hemorrhage 09/2019
1	Cardiomyopathies (Cardiomyopathy) 12/2013
1	Left Ventricular Dysfunction 03/2013
1	Ischemia 05/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2012
1	Frailty 03/2012
1	Hiccup (Hiccups) 12/2011
1	Urinary Retention 10/2011
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2011
1	Drug-Related Side Effects and Adverse Reactions 02/2011
1	Heart Diseases (Heart Disease) 09/2010
1	Hypertension (High Blood Pressure) 05/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Chronic Renal Insufficiency 01/2010
1	Coronary Disease (Coronary Heart Disease) 07/2009
1	Systolic Heart Failure 11/2008
1	Coronary Stenosis (Coronary Artery Stenosis) 06/2008
1	Anemia 03/2005
1	Chest Pain (Chest Pains) 03/2005

Drug/Important Bio-Agent (IBA)

3	DiureticsIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 11/2021 - 12/2011
2	SodiumIBA 01/2020 - 01/2018
2	Mineralocorticoid Receptor AntagonistsIBA 03/2013 - 11/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2008 - 03/2005
1	Oxygen (Dioxygen)IBA 01/2022
1	Dobutamine FDA LinkGeneric 11/2021
1	Milrinone (Primacor)FDA LinkGeneric 11/2021
1	Prothrombin (Factor II)IBA 09/2019
1	Antihypertensive Agents (Antihypertensives)IBA 09/2019
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 09/2019
1	Anticoagulant Reversal AgentsIBA 09/2019
1	4-methyl-2,3-secocholestane-2,3-diolIBA 09/2019
1	recombinant FVIIa (rFVIIa)FDA Link 09/2019
1	Bronchodilator Agents (Bronchodilators)IBA 05/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 05/2012
1	Baclofen FDA LinkGeneric 12/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2011
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2011
1	Carvedilol (Coreg)FDA LinkGeneric 10/2011
1	Bisoprolol (Concor)FDA LinkGeneric 10/2011
1	Anti-Infective Agents (Microbicides)IBA 02/2011
1	Investigational DrugsIBA 05/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2010
1	Simvastatin (Zocor)FDA LinkGeneric 07/2009
1	Spironolactone (Aldactone)FDA LinkGeneric 11/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2008
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 11/2008
1	Hydralazine (Apresoline)FDA LinkGeneric 11/2008
1	Angiotensin Receptor AntagonistsIBA 11/2008
1	Prostaglandins AIBA 11/2007

Therapy/Procedure

15	Therapeutics 01/2022 - 11/2008
6	Heart-Assist Devices 09/2019 - 04/2004
5	Heart Transplantation (Grafting, Heart) 01/2022 - 11/2018
4	Transplantation 11/2021 - 05/2011
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2010 - 08/2009
1	Extracorporeal Membrane Oxygenation 01/2022
1	Continuous Renal Replacement Therapy 09/2021
1	Length of Stay 01/2020
1	Cardiac Resynchronization Therapy 09/2012
1	Drug Therapy (Chemotherapy) 12/2011
1	Liver Transplantation 06/2008
1	Denervation 03/2005